ADAKVEO
LIVE

Serial Number

79236498

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 12, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ADAKVEO Trademark

Serial Number: 79236498 • Registration: 5609269

ADAKVEO is a trademark filed by NOVARTIS AG on May 12, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 12, 2018

Registration Date

November 20, 2018

Published for Opposition

September 4, 2018

Goods & Services

[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; ] pharmaceutical preparations for use in hematology [ and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
Sep 30, 2025 XXSS
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Sep 30, 2025 INNA
GENERIC MADRID TRANSACTION CREATED
Sep 30, 2025 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 25, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 25, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Sep 25, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 23, 2024 APRE
TEAS SECTION 71 RECEIVED
Jan 19, 2024 ES71
INTERNATIONAL REGISTRATION RENEWED
Aug 2, 2021 RNWL
NOTIFICATION PROCESSED BY IB
Mar 1, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 2, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 2, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Dec 20, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Nov 20, 2018 R.PR
PUBLISHED FOR OPPOSITION
Sep 4, 2018 PUBO
NOTICE OF PUBLICATION
Aug 15, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 28, 2018 CNSA
ASSIGNED TO EXAMINER
Jul 27, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 24, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 16, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 12, 2018 SDRC